Market Overview

Morning Market Losers

Share:

Celsus Therapeutics Plc (NASDAQ: CLTX) shares dropped 81.36% to $1.15 on failed Phase 2 MRX-6 cream trial.

Vascular Biogenics Ltd.(NASDAQ: VBLT) shares dipped 55.28% to $6.31 after the company announced the removal of the FDA partial clinical hold on VB-111. VBL Therapeutics announced its plans to discontinue the development of VB-201 in ulcerative colitis and psoriasis following Phase 2 results.

Helix Energy Solutions Group, Inc. (NYSE: HLX) shares slipped 13.36% to $16.53 after the company reported downbeat Q4 results.

Vanguard Natural Resources, LLC (NYSE: VNR) shares dropped 9.18% to $16.43 after the company reported Q4 preliminary adjusted profit of $0.19 per unit, versus analysts' estimates of $0.26 per unit. The company also lowered its January distribution from $0.21 to $0.1175 per unit.

CoStar Group Inc. (NASDAQ: CSGP) shares declined 7.15% to $186.19 after the company issued a weak Q1 and FY15 earnings guidance.

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) fell 6.86% to $110.42 following wider than expected quarterly loss.

Walter Energy, Inc. (NYSE: WLT) shares dropped 4.50% to $1.04 after the company reported a wider-than-expected Q4 loss.

Macy's, Inc.(NYSE: M) shares declined 1.90% to $63.10. Analysts at Barclays initiated coverage on Macy's with a Underweight rating.

Posted-In: market losersNews Movers & Shakers Intraday Update Markets

 

Related Articles (AGIO + CLTX)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com